Three groups of isolates, each comprising four isolates of Candida species, were selected for their diversity of susceptibilities to amphotericin B, flucytosine, or ketoconazole. The isolates were distributed in duplicate and in blinded fashion to three laboratories where a total of eight procedures were performed for each drug. From the decoded results, intralaboratory variability among replicate determinations was found usually to fall within a fourfold range. Interlaboratory variation, however, was 16-fold or greater for all isolates, ranging to 50,000-fold differences for some isolates. Relative susceptibilities of isolates within each method could be determined in 11 of the 24 drug-method combinations and agreed with the reference rank order in all but one instance. Our findings underscore the lack of agreement among laboratories for the susceptibility testing of yeasts but indicate that such differences could likely be resolved by standardization without loss of clinical value.
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Susceptibility testing of fungi, including yeasts such as Candida species, is unstandardized. Numerous broth and agar dilution methods and the application of these methods in specific laboratories under differing test conditions may produce significantly divergent test results (7) . Little information has been published concerning differences in results produced by broth and agar dilution procedures. However, a recent interlaboratory comparison testing the reproducibility of a single broth dilution method found an unacceptable discordance of results (3) . This lack of agreement undermines the interpretation of in vitro results and raises the question of which method correlates best with the results of treatment.
It is possible for the susceptibility of an isolate, relative to others, to be similar even when there exist wide differences in endpoint results when tested under different conditions. That a consistent rank order of susceptibility might exist for yeasts has been suggested in previous reports (3, 4, 8, 12) . Unfortunately, in some of those studies identical results were produced by many isolates, and in others values were beyond the highest or lowest drug dilutions tested. Both circumstances restricted detailed determination of rank order. However, if relative sensitivities were constant, even by widely diverse methodology, then each method could be expected to produce equivalent correlations with clinical responses, and the standardization process would thus be significantly simplified.
Because of the limitations of previous studies, we chose to compare results obtained with divergent methods for groups of candidal isolates that had been selected to encompass a broad range of in vitro susceptibilities to commonly used antifungal agents. The results of these comparisons are the basis of this report. * Corresponding author.
MATERIALS AND METHODS
Antifungal drugs. Three antifungal agents were used in this study: amphotericin B (E. R. Squibb & Sons, Princeton, N.J.), flucytosine (Roche Laboratories, Nutley, N.J.), and ketoconazole (Janssen Pharmaceutica, Inc., Piscataway, N.J.).
Candida strains. Four strains of Candida species for each antifungal agent were selected to obtain a wide range of susceptibility results ( Table 1 ). The selected isolates differed at least twofold, and most differed by fourfold or greater, for each antifungal agent as judged by the reference method. The source of the isolates and their designations in previous studies are given in Table 1 .
Antifungal susceptibility test procedures. Investigators invited to participate in this collaboration had an established interest in antifungal susceptibility tests. They were asked to use whatever procedures would normally be applied in their own laboratories to susceptibility testing of yeasts for each of the three agents. MICs were determined by broth dilution and agar dilution methods (termed broth MIC and agar MIC, respectively), minimal fungicidal concentrations were determined by a broth dilution method, and a partial inhibitory concentration (IC1/2) was determined by a broth dilution method utilizing a turbidimetric endpoint (1, 2, 5, 8, 10, 11) .
In addition, IC1,2 determinations were arbitrarily selected as the reference method to rank Candida species isolates for inclusion in the study. The methods performed by each laboratory are shown in Table 2 .
Study design. Except for IC1,2 studies performed by the reference laboratory, trials by participant laboratories were blinded. Each investigator received duplicate subcultures of all isolates numerically coded (i.e., 24 slants in all) and data sheets. Accompanying instructions indicated which four isolates should be tested with each of the three antifungal each isolate relative to the others, since the degree of intralaboratory variability precluded ascribing significance to more precise quantitation. In contrast to the very discrepant results among methods as measured by absolute test results, the relative susceptibilities of isolates exhibited general agreement ( Fig. 1 through 3) . For amphotericin B, several of the test results failed to discriminate among the four isolates. However, broth MIC results performed within the same center by two different technicians both agreed with the rank order of susceptibility established by the reference results. For flucytosine, five of the eight blinded studies demonstrated differences in relative susceptibilities that were in agreement with the reference method. The three duplicate trials that did not detect differences were all of different methods. In one, fungicidal concentrations failed to be obtained at all concentrations. The other two reported MIC results with broth and agar methods, respectively.
For ketoconazole, four of the eight blinded sets of results demonstrated significant differences among isolates. Three of these, two of which were agar MIC methods, agreed with the reference results. In striking contrast, results from another agar MIC method produced exactly the opposite pattern. Intramethod replicate agreement was very good for these methods (Table 3) for this disagreement are not understood but should be pursued in future studies. In addition, it should also be noted that several of the methods did not discriminate among the isolates with respect to their susceptibilities. Although for one method this was due to results being above the highest drug concentrations tested, for most endpoints were reached, and isolates were reported within eightfold of each other. It is possible that if intralaboratory variation were reduced or if many more isolates were studied for each drug by these methods rank orders might be established.
The primary purpose which this study accomplished was to compare the relative susceptibility of various yeasts by several commonly employed methods. Since a similar study had not previously been published, ours was designed to be relatively small. Furthermore, since most of our isolates were C. albicans, additional studies with more strains of other species of yeasts may be necessary to insure the general validity of our findings. Finally, we would urge caution in applying comparisons of our results to broth and agar dilutions too broadly. Such comparisons on a larger scale would be of value in efforts to standardize this field of testing.
